CH397665A - Verfahren zur Herstellung von 6B,16B-dimethyl-11-ketoprogesteron - Google Patents
Verfahren zur Herstellung von 6B,16B-dimethyl-11-ketoprogesteronInfo
- Publication number
- CH397665A CH397665A CH291360A CH291360A CH397665A CH 397665 A CH397665 A CH 397665A CH 291360 A CH291360 A CH 291360A CH 291360 A CH291360 A CH 291360A CH 397665 A CH397665 A CH 397665A
- Authority
- CH
- Switzerland
- Prior art keywords
- ketoprogesterone
- dimethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80009159A | 1959-03-18 | 1959-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH397665A true CH397665A (de) | 1965-08-31 |
Family
ID=25177459
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH291360A CH397665A (de) | 1959-03-18 | 1960-03-15 | Verfahren zur Herstellung von 6B,16B-dimethyl-11-ketoprogesteron |
| CH230365A CH396895A (de) | 1959-03-18 | 1960-03-15 | Verfahren zur Herstellung neuer Steroidverbindungen |
| CH230465A CH396896A (de) | 1959-03-18 | 1960-03-15 | Verfahren zur Herstellung neuer Steroidverbindungen |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH230365A CH396895A (de) | 1959-03-18 | 1960-03-15 | Verfahren zur Herstellung neuer Steroidverbindungen |
| CH230465A CH396896A (de) | 1959-03-18 | 1960-03-15 | Verfahren zur Herstellung neuer Steroidverbindungen |
Country Status (2)
| Country | Link |
|---|---|
| CH (3) | CH397665A (de) |
| GB (2) | GB898295A (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3227312A1 (de) * | 1982-07-19 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung |
| JP7330101B2 (ja) | 2016-11-08 | 2023-08-21 | レゲネロン ファーマシューティカルス,インコーポレーテッド | ステロイド及びそのタンパク質コンジュゲート |
| US11491237B2 (en) | 2017-05-18 | 2022-11-08 | Regeneron Pharmaceuticals, Inc. | Cyclodextrin protein drug conjugates |
| MX2020004691A (es) | 2017-11-07 | 2020-08-20 | Regeneron Pharma | Enlazadores hidrofilicos para conjugados anticuerpo-farmaco. |
| BR112020013492A2 (pt) | 2018-01-08 | 2020-12-08 | Regeneron Pharmaceuticals, Inc. | Esteroides e conjugados de anticorpo dos mesmos |
| KR20210008008A (ko) | 2018-05-09 | 2021-01-20 | 리제너론 파마슈티칼스 인코포레이티드 | 항-msr1 항체 및 이의 사용 방법 |
-
1960
- 1960-03-14 GB GB2909561A patent/GB898295A/en not_active Expired
- 1960-03-14 GB GB892260A patent/GB898291A/en not_active Expired
- 1960-03-15 CH CH291360A patent/CH397665A/de unknown
- 1960-03-15 CH CH230365A patent/CH396895A/de unknown
- 1960-03-15 CH CH230465A patent/CH396896A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB898295A (en) | 1962-06-06 |
| CH396895A (de) | 1965-08-15 |
| GB898291A (en) | 1962-06-06 |
| CH396896A (de) | 1965-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT230379B (de) | Verfahren zur Herstellung von 2,4-Diamino-5-arylmethylpyrimidinen | |
| CH370197A (de) | Verfahren zur Herstellung von Actinospectacin | |
| CH408030A (de) | Verfahren zur Herstellung von 1,4-Benzodiazepin-4-oxyden | |
| CH387047A (de) | Verfahren zur Herstellung von Ketosidopurinen | |
| CH393338A (de) | Verfahren zur Herstellung von 1-Aryl-4,5-dihalogenpyridazonen-(6) | |
| CH400146A (de) | Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-1,4-pregnadien-3,20-dion-17-acylaten | |
| CH397665A (de) | Verfahren zur Herstellung von 6B,16B-dimethyl-11-ketoprogesteron | |
| CH385246A (de) | Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-dinitril | |
| CH396026A (de) | Verfahren zur Herstellung von Halogenalkylaminen | |
| CH387606A (de) | Verfahren zur Herstellung von Tetrahydroxydibor | |
| CH399742A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH373026A (de) | Verfahren zur Herstellung von 2-Methyl-2-propyl-propandiol-1,3 | |
| CH391692A (de) | Verfahren zur Herstellung von B-2,6-Dichlor-benzaldoxim | |
| CH389610A (de) | Verfahren zur Herstellung von d-2-Phenyl-3-methyl-tetrahydro-1,4-oxazin | |
| CH372297A (de) | Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden | |
| CH380730A (de) | Verfahren zur Herstellung von 4-Methoxy-2-methyl-6-sulfanilamidopyrimidin | |
| CH380727A (de) | Verfahren zur Herstellung von 2,4-Dioxy-chinolinen | |
| CH400110A (de) | Verfahren zur Herstellung von 2-Trifluormethylbenzhydrol | |
| CH378344A (de) | Verfahren zur Herstellung von 2-Amino-anthrachinonen | |
| CH420142A (de) | Verfahren zur Herstellung von 3B,20-Diacyloxy-9a,11B-dichlor-17,20-epoxy-16-methyl-5a-pregnanen | |
| CH376912A (de) | Verfahren zur Herstellung von 11a,18-Dihydroxy-progesteron | |
| CH414648A (de) | Verfahren zur Herstellung von 2,6-Dialkoxy-4-amino-pyrimidinen | |
| CH408935A (de) | Verfahren zur Herstellung von 1-Phenyl-3-methoxy-5-sulfanilamido-pyrazol-1,2 | |
| CH383953A (de) | Verfahren zur Herstellung von 18,20-Oxido-steroiden | |
| CH377809A (de) | Verfahren zur Herstellung von 3,12-Dioxy-11-oxo-23-bromspirostan |